IRCSX
Price
$15.56
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
1.3B
PICOX
Price
$46.28
Change
-$0.24 (-0.52%)
Updated
Jun 2 closing price
Net Assets
342.72M
Interact to see
Advertisement

IRCSX vs PICOX

Header iconIRCSX vs PICOX Comparison
Open Charts IRCSX vs PICOXBanner chart's image
IRCSX vs PICOX Comparison Chart in %
View a ticker or compare two or three
VS
IRCSX vs. PICOX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRCSX is a Hold and PICOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
IRCSX has more cash in the bank: 1.3B vs. PICOX (343M). PICOX pays higher dividends than IRCSX: PICOX (5.98) vs IRCSX (1.94). IRCSX was incepted earlier than PICOX: IRCSX (10 years) vs PICOX (8 years). IRCSX (1.33) is less costly to investors than PICOX (1.15). IRCSX is a more actively managed with annual turnover of: 57.00 vs. PICOX (30.00). PICOX has a lower initial minimum investment than IRCSX: PICOX (0) vs IRCSX (5000). IRCSX annual gain was more profitable for investors over the last year : 13.80 vs. PICOX (4.45). IRCSX return over 5 years is better than : 26.25 vs. PICOX (11.90).
IRCSXPICOXIRCSX / PICOX
Total Expense Ratio1.331.05127%
Annual Report Gross Expense Ratio1.331.15116%
Fund Existence10 years8 years-
Gain YTD14.1603.217440%
Front LoadN/AN/A-
Min. Initial Investment50000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B343M380%
Annual Yield % from dividends1.945.9832%
Returns for 1 year13.804.45310%
Returns for 3 years53.7640.32133%
Returns for 5 years26.2511.90221%
Returns for 10 years75.20N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNM50.481.40
+2.85%
Core & Main
STEL37.370.59
+1.60%
Stellar Bancorp
CRACU10.22N/A
N/A
Crown Reserve Acquisition Corp. I
DWTX1.68-0.02
-1.18%
Dogwood Therapeutics Inc
IPSC2.18-0.18
-7.63%
Century Therapeutics